Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

INSM | Insmed Inc

Index	RUT	P/E	-	EPS (ttm)	-5.24	Insider Own	2.91%	Shs Outstand	143.80M	Perf Week	-3.19%
Market Cap	3.67B	Forward P/E	-	EPS next Y	-4.59	Insider Trans	-1.07%	Shs Float	139.62M	Perf Month	18.00%
Income	-695.84M	PEG	-	EPS next Q	-1.13	Inst Own	101.75%	Short Float / Ratio	9.80% / 10.36	Perf Quarter	25.49%
Sales	269.47M	P/S	13.61	EPS this Y	-33.37%	Inst Trans	-4.60%	Short Interest	13.68M	Perf Half Y	48.77%
Book/sh	-1.09	P/B	-	EPS next Y	11.89%	ROA	-55.83%	Target Price	40.77	Perf Year	19.33%
Cash/sh	6.38	P/C	4.00	EPS next 5Y	-	ROE	-1453.41%	52W Range	16.04 - 27.59	Perf YTD	27.63%
Dividend	-	P/FCF	-	EPS past 5Y	-6.25%	ROI	-59.10%	52W High	-7.58%	Beta	1.47
Dividend %	-	Quick Ratio	4.77	Sales past 5Y	270.57%	Gross Margin	76.99%	52W Low	58.98%	ATR	0.88
Employees	736	Current Ratio	5.15	Sales Q/Q	18.41%	Oper. Margin	-243.22%	RSI (14)	55.07	Volatility	3.48% 3.63%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-122.55%	Profit Margin	-258.22%	Rel Volume	0.48	Prev Close	25.90
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 03 BMO	Payout	-	Avg Volume	1.32M	Price	25.50
Recom	1.08	SMA20	-0.70%	SMA50	9.50%	SMA200	25.57%	Volume	414,589	Change	-1.54%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-23	Initiated	Guggenheim	Buy	$50
Dec-09-22	Initiated	Mizuho	Buy	$28
Dec-07-22	Initiated	Barclays	Overweight	$37
Nov-18-22	Initiated	BofA Securities	Buy	$39
Apr-27-22	Initiated	Goldman	Buy	$56
Dec-06-21	Initiated	JP Morgan	Overweight	$45
Oct-19-21	Resumed	Morgan Stanley	Overweight	$56 → $52
Oct-19-21	Resumed	Monness Crespi & Hardt	Buy	$52
Oct-08-21	Initiated	Cantor Fitzgerald	Overweight	$60
Apr-26-21	Resumed	Credit Suisse	Outperform	$60
Dec-17-20	Initiated	Berenberg	Buy	$48
Oct-12-20	Resumed	Stifel	Buy	$44
Sep-03-19	Initiated	Goldman	Buy	$30
Apr-09-19	Reiterated	H.C. Wainwright	Buy	$43 → $52
Feb-15-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$40
Jan-17-19	Upgrade	Goldman	Neutral → Buy
Jan-02-19	Initiated	Canaccord Genuity	Buy	$20
Aug-06-18	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jul-23-18	Initiated	Goldman	Neutral	$32
Apr-23-18	Upgrade	Credit Suisse	Neutral → Outperform

Show Previous Ratings

Sep-26-23 08:00AM	Insmed To Present at Chardan's 7th Annual Genetic Medicines Conference (PR Newswire)
Sep-08-23 02:09PM	Why Shares of Insmed Are Soaring This Week (Motley Fool)
08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Sep-06-23 08:00AM	Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
07:46AM	Insmed (INSM) Up on Positive Data From MAC Lung Disease Study (Zacks)
07:32PM	Loading…
Sep-05-23 07:32PM	Insmed (INSM): A Hidden Gem or Just Modestly Undervalued? (GuruFocus.com) +16.48%
04:10PM	Insmed Is Making A Comeback Why Shares Hit A Year High In Record Volume (Investor's Business Daily)
12:18PM	Insmed Inc's Meteoric Rise: Unpacking the 34% Surge in Just 3 Months (GuruFocus.com)
11:52AM	Why Insmed Stock Is Soaring Today (Motley Fool)
07:00AM	INSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MAC (PR Newswire)
Aug-04-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Aug-03-23 09:05AM	Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:55AM	Insmed: Q2 Earnings Snapshot (AP Finance)
07:30AM	Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update (PR Newswire)
Jul-20-23 08:00AM	Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023 (PR Newswire)
08:00AM	Loading…
Jul-07-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jun-30-23 06:14AM	Insmed (NASDAQ:INSM) shareholders have endured a 31% loss from investing in the stock three years ago (Simply Wall St.)
Jun-07-23 08:00AM	Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference (PR Newswire)
Jun-06-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-22-23 04:05PM	Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference (PR Newswire)
May-08-23 07:30AM	Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More" (PR Newswire)
May-05-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-04-23 08:55AM	Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:50AM	Insmed: Q1 Earnings Snapshot (AP Finance)
07:30AM	Insmed Reports First Quarter 2023 Financial Results and Provides Business Update (PR Newswire)
May-02-23 10:01AM	Revance Therapeutics, Inc. (RVNC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-27-23 10:03AM	Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-24-23 08:00AM	Insmed to Host Investor and Analyst Event on May 8, 2023 (PR Newswire)
Apr-20-23 08:00AM	Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023 (PR Newswire)
Apr-18-23 06:34AM	Insmed Incorporated's (NASDAQ:INSM) Business Is Trailing The Industry But Its Shares Aren't (Simply Wall St.)
08:00AM	Loading…
Apr-06-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Mar-31-23 08:00AM	Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis (PR Newswire)
Mar-24-23 04:22PM	Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference (PR Newswire)
Mar-23-23 06:51AM	A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM) (Simply Wall St.)
Mar-21-23 05:10PM	12 Best Biotech Stocks To Buy Under $20 (Insider Monkey)
Mar-03-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Mar-01-23 08:00AM	Insmed To Present at Two March Conferences (PR Newswire)
Feb-24-23 05:42AM	Insmed Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Feb-23-23 09:15AM	Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (PR Newswire)
Feb-19-23 07:49AM	Insiders of Insmed Incorporated (NASDAQ:INSM) are up 17% on their US$1.7m purchase after Insmed Incorporated (NASDAQ:INSM) rose 5.0% last week (Simply Wall St.)
Feb-16-23 10:01AM	Y-mAbs Therapeutics, Inc. (YMAB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-09-23 10:01AM	Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:00AM	Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023 (PR Newswire)
Feb-07-23 08:00AM	Insmed To Present at the SVB Securities Global Biopharma Conference (PR Newswire)
Feb-03-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jan-26-23 10:45AM	Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum (Business Wire)
Jan-24-23 09:55AM	Wall Street Analysts Believe Insmed (INSM) Could Rally 98.26%: Here's is How to Trade (Zacks)
Jan-20-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) +5.72%
Jan-19-23 05:48AM	The past five years for Insmed (NASDAQ:INSM) investors has not been profitable (Simply Wall St.) +5.39%
Jan-06-23 08:00AM	Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference (PR Newswire) -6.28%
Jan-03-23 08:00AM	Insmed To Present at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-06-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-30-22 08:00AM	Insmed To Present at the Nasdaq 47th Investor Conference (PR Newswire)
Nov-04-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-03-22 08:26PM	These 2 Stocks May Be Reaching a Bottom; Insiders Are Buying the Dip (TipRanks)
Nov-01-22 08:00AM	Insmed To Present at Three November Conferences (PR Newswire)
Oct-27-22 04:05PM	Insmed Ranks No. 1 on Science's 2022 Top Biopharma Employers List (PR Newswire)
08:45AM	Insmed (INSM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Insmed Reports Third Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
Oct-25-22 10:01AM	Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-20-22 10:01AM	Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-19-22 05:14PM	Why Insmed's Shares Fell 14.7% on Wednesday (Motley Fool) -14.68%
08:50AM	Insmed Announces Strategic Financings Totaling $775 Million (PR Newswire)
Oct-13-22 08:00AM	Insmed to Host Third Quarter 2022 Financial Results Conference Call on Thursday, October 27, 2022 (PR Newswire)
Oct-07-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Oct-06-22 08:00AM	Insmed Holds Inaugural Global Day of Good - A Company-Wide Day of Service (PR Newswire)
Oct-04-22 12:00PM	Insmed (INSM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-22-22 01:31AM	Bluebird (BLUE) Surges 15.7%: Is This an Indication of Further Gains? (Zacks)
Sep-18-22 09:55AM	Are Investors Undervaluing Insmed Incorporated (NASDAQ:INSM) By 47%? (Simply Wall St.)
Sep-07-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Sep-06-22 08:00AM	Insmed To Present at Two September Conferences (PR Newswire)
Aug-08-22 01:23PM	Investors bid Insmed (NASDAQ:INSM) up US$686m despite increasing losses YoY, taking five-year CAGR to 19% (Simply Wall St.)
Aug-05-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) +10.73%
Aug-04-22 09:35AM	Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +15.17%
07:30AM	Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
Aug-01-22 10:00AM	Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline (Zacks) -5.61%
Jul-28-22 10:03AM	Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-21-22 08:00AM	Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022 (PR Newswire)
Jul-08-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) +6.80%
Jun-09-22 09:42AM	10 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen (Insider Monkey)
Jun-03-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) +5.91%
May-23-22 08:00AM	Insmed Names Drayton Wise Chief Commercial Officer (PR Newswire)
May-17-22 06:05PM	Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference (PR Newswire) +9.14%
08:00AM	Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference (PR Newswire)
May-15-22 08:52AM	Trade Alert: The Independent Director Of Insmed Incorporated (NASDAQ:INSM), Melvin Sharoky, Has Just Spent US$344k Buying 8.7% More Shares (Simply Wall St.)
May-06-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) -10.48%
May-05-22 09:05AM	Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Insmed Reports First Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
May-04-22 09:10PM	Goldman Sachs Sees These 2 Strong Buy Stocks Skyrocketing Over 70% (TipRanks)
Apr-28-22 03:02PM	Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-21-22 08:00AM	Insmed to Host First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022 (PR Newswire) -5.59%
Apr-07-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Mar-28-22 08:00AM	Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference (PR Newswire)
Mar-04-22 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Mar-03-22 08:00AM	Insmed To Present at the Cowen 42nd Annual Health Care Conference (PR Newswire)
Feb-17-22 08:25AM	Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update (PR Newswire)
Feb-10-22 03:01PM	Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:00AM	Insmed To Present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference (PR Newswire)

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smith Michael Alexander	General Counsel, Senior VP	Jul 11	Sale	20.18	740	14,933	77,142	Jul 13 04:01 PM
Adsett Roger	Chief Operating Officer	Jun 13	Sale	19.32	8,981	173,513	151,352	Jun 15 04:05 PM
Flammer Martina M.D.	Chief Medical Officer	Jun 13	Sale	19.27	8,868	170,886	106,038	Jun 15 04:06 PM
Wise John Drayton	Chief Commercial Officer	May 25	Sale	18.95	3,366	63,786	102,681	May 26 04:05 PM
Lewis William	Chair and CEO	May 17	Sale	18.12	7,099	128,634	341,345	May 17 04:11 PM
Adsett Roger	Chief Operating Officer	May 17	Sale	18.12	2,448	44,358	160,333	May 17 04:07 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 17	Sale	18.16	1,972	35,812	93,525	May 17 04:13 PM
Wise John Drayton	Chief Commercial Officer	May 17	Sale	18.17	1,913	34,759	106,047	May 17 04:16 PM
Smith Michael Alexander	General Counsel, Senior VP	May 17	Sale	18.18	1,263	22,961	77,082	May 17 04:14 PM
Lewis William	Chair and CEO	May 16	Sale	18.41	3,714	68,375	348,444	May 17 04:11 PM
Flammer Martina M.D.	Chief Medical Officer	May 16	Sale	18.43	1,718	31,663	114,906	May 17 04:10 PM
Bonstein Sara	Chief Financial Officer	May 16	Sale	18.47	1,610	29,737	117,619	May 17 04:09 PM
Adsett Roger	Chief Operating Officer	May 16	Sale	18.39	1,521	27,971	162,781	May 17 04:07 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 16	Sale	18.45	1,217	22,454	95,497	May 17 04:13 PM
Smith Michael Alexander	General Counsel, Senior VP	May 16	Sale	18.43	475	8,754	78,345	May 17 04:14 PM
Wise John Drayton	Chief Commercial Officer	May 16	Sale	18.44	381	7,026	107,960	May 17 04:16 PM
SHAROKY MELVIN MD	Director	May 15	Buy	19.29	10,000	192,900	10,000	May 17 04:06 PM
SHAROKY MELVIN MD	Director	May 15	Buy	19.29	10,000	192,900	298,615	May 17 04:06 PM
Lewis William	Chair and CEO	May 15	Sale	19.23	6,048	116,303	352,158	May 17 04:11 PM
Adsett Roger	Chief Operating Officer	May 15	Sale	19.27	2,847	54,862	164,302	May 17 04:07 PM
Flammer Martina M.D.	Chief Medical Officer	May 15	Sale	19.28	2,576	49,665	116,624	May 17 04:10 PM
Bonstein Sara	Chief Financial Officer	May 15	Sale	19.30	2,210	42,653	119,229	May 17 04:09 PM
Smith Michael Alexander	General Counsel, Senior VP	May 15	Sale	19.24	1,897	36,498	78,820	May 17 04:14 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 15	Sale	19.22	1,830	35,173	96,714	May 17 04:13 PM
Wise John Drayton	Chief Commercial Officer	May 15	Sale	19.29	593	11,439	108,341	May 17 04:16 PM
Lewis William	Chair and CEO	May 12	Option Exercise	12.44	233,924	2,910,015	233,924	May 15 04:12 PM
Lewis William	Chair and CEO	Jan 10	Sale	18.00	6,994	125,892	265,067	Jan 12 04:10 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 10	Sale	18.06	3,439	62,108	72,763	Jan 12 04:09 PM
Adsett Roger	Chief Operating Officer	Jan 10	Sale	17.99	3,194	57,460	135,487	Jan 12 04:06 PM
Bonstein Sara	Chief Financial Officer	Jan 10	Sale	18.12	2,857	51,769	66,031	Jan 12 04:08 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 10	Sale	17.95	2,435	43,708	72,159	Jan 12 04:11 PM
Smith Michael Alexander	General Counsel, Senior VP	Jan 10	Sale	17.93	1,836	32,919	54,332	Jan 12 04:13 PM
Wise John Drayton	Chief Commercial Officer	Jan 10	Sale	17.96	779	13,991	77,272	Jan 12 04:14 PM
Lewis William	Chair and CEO	Jan 05	Sale	19.80	7,008	138,758	249,708	Jan 06 04:24 PM
Adsett Roger	Chief Operating Officer	Jan 05	Sale	19.75	3,044	60,119	131,083	Jan 06 04:08 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 05	Sale	19.73	1,448	28,569	68,262	Jan 06 04:27 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 05	Sale	19.73	1,374	27,109	65,058	Jan 06 04:22 PM
Wise John Drayton	Chief Commercial Officer	Jan 05	Sale	19.74	1,160	22,898	70,453	Jan 06 04:30 PM
Smith Michael Alexander	General Counsel, Senior VP	Jan 05	Sale	19.72	720	14,198	49,836	Jan 06 04:29 PM
Adsett Roger	Chief Operating Officer	Nov 22	Sale	18.80	11,855	222,874	134,127	Nov 22 05:03 PM
Wise John Drayton	Chief Commercial Officer	Nov 22	Sale	18.84	7,154	134,781	71,613	Nov 22 05:05 PM
SHAROKY MELVIN MD	Director	Nov 01	Buy	17.70	10,000	177,000	15,900	Nov 02 04:23 PM
LEE LEO	Director	Oct 31	Buy	17.69	45,000	796,050	98,265	Nov 02 04:20 PM
SHAROKY MELVIN MD	Director	Oct 31	Buy	17.53	20,000	350,600	281,021	Nov 02 04:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INSM | Insmed Inc

Upgrade your FINVIZ experience